0001193805-24-000757.txt : 20240606
0001193805-24-000757.hdr.sgml : 20240606
20240606083135
ACCESSION NUMBER: 0001193805-24-000757
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldstein Julie Ann
CENTRAL INDEX KEY: 0001917358
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38538
FILM NUMBER: 241023907
MAIL ADDRESS:
STREET 1: 205 FORGE WAY
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: electroCore, Inc.
CENTRAL INDEX KEY: 0001560258
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 203454976
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 FORGE WAY
STREET 2: SUITE 205
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
BUSINESS PHONE: 973-290-0097
MAIL ADDRESS:
STREET 1: 200 FORGE WAY
STREET 2: SUITE 205
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
FORMER COMPANY:
FORMER CONFORMED NAME: ElectroCore, LLC
DATE OF NAME CHANGE: 20121012
4
1
e663688_4-goldstein.xml
X0508
4
2024-06-05
0
0001560258
electroCore, Inc.
ECOR
0001917358
Goldstein Julie Ann
200 FORGE WAY, SUITE 205
ROCKAWAY
NJ
07866
1
0
0
0
0
Common Stock
2024-06-05
4
A
0
7701
6.43
A
77380
D
Warrants to Purchase Common Stock
6.43
2024-06-05
4
P
0
3850
0.0625
A
2024-06-05
2029-06-05
Common Stock
3850
3850
D
On June 5, 2024, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 7,701 Units, each Unit consisting of (i) one share of the Issuer's Common Stock and (ii) one Warrant to purchase one-half share of the Issuer's Common Stock. The combined purchase price in the Offering was $6.4925 per Unit, inclusive of $6.43 per share of Common Stock and $0.0625 per Warrant. Each Warrant entitles the holder thereof to purchase one half of a share of Common Stock, is immediately exercisable from the date of issuance at an exercise price of $6.43 per share, and expires five years after issuance.
Includes 7,500 shares that have vested pursuant to previously issued Deferred Stock Units; 2,500 of such shares will vest monthly through March 15, 2025,
provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. All such vested and unvested
shares were previously reported on Form 4 filings at the time of grant.
Includes 1,665 shares held in NeuroSpine Ventures; an entity in which the Reporting Person has no voting or dispositive power over the shares. Accordingly, the Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
/s/ Ira Kotel, attorney-in-fact
2024-06-06